메뉴 건너뛰기




Volumn 17, Issue 2, 2012, Pages 175-198

Inhibitors of cell cycle kinases: Recent advances and future prospects as cancer therapeutics

Author keywords

Aurora kinase; Cell cycle; Cyclin dependent kinase; Drug discovery; Polo like kinase

Indexed keywords

6 ACETYL 8 CYCLOPENTYL 5 METHYL 2 [5 (1 PIPERAZINYL) 2 PYRIDINYLAMINO] 8H PYRIDO[2,3 D]PYRIMIDIN 7 ONE; AG024322; AT7519M; AURORA A KINASE; AZD5438; BAY1000394; BORTEZOMIB; CARBOPLATIN; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 3; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR; DEXAMETHASONE; DINACICLIB; FLAVOPIRIDOL; GEMCITABINE; LETROZOLE; MILCICLIB; N [5 (5 TERT BUTYL 2 OXAZOLYLMETHYLTHIO) 2 THIAZOLYL]ISONIPECOTAMIDE; OLOMOUCINE; P1446A05; P27600; PHA793887; POLO LIKE KINASE; R547; RGB286638; ROSCOVITINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; CYCLIN DEPENDENT KINASE; PROTEIN KINASE INHIBITOR;

EID: 84861497210     PISSN: 08939675     EISSN: 21626448     Source Type: Journal    
DOI: 10.1615/CritRevOncog.v17.i2.40     Document Type: Article
Times cited : (51)

References (115)
  • 1
    • 79960088065 scopus 로고    scopus 로고
    • Physiological relevance of cell cycle kinases
    • Malumbres M. Physiological relevance of cell cycle kinases. Physiol Rev. 2011;91:973-1007.
    • (2011) Physiol Rev , vol.91 , pp. 973-1007
    • Malumbres, M.1
  • 2
    • 60749109846 scopus 로고    scopus 로고
    • Cell cycle, CDKs and cancer: A changing paradigm
    • Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009;9:153-66.
    • (2009) Nat Rev Cancer , vol.9 , pp. 153-166
    • Malumbres, M.1    Barbacid, M.2
  • 4
    • 67650073265 scopus 로고    scopus 로고
    • Cell cycle kinases as therapeutic targets for cancer
    • Lapenna S, Giordano A. Cell cycle kinases as therapeutic targets for cancer. Nat Rev Drug Discov. 2009;8:547-66.
    • (2009) Nat Rev Drug Discov , vol.8 , pp. 547-566
    • Lapenna, S.1    Giordano, A.2
  • 5
    • 67650777303 scopus 로고    scopus 로고
    • Development of cellcycle inhibitors for cancer therapy
    • Dickson MA, Schwartz GK. Development of cellcycle inhibitors for cancer therapy. Curr Oncol. 2009;16:36-43.
    • (2009) Curr Oncol , vol.16 , pp. 36-43
    • Dickson, M.A.1    Schwartz, G.K.2
  • 7
    • 8644219655 scopus 로고    scopus 로고
    • Living with or without cyclins and cyclin-dependent kinases
    • Sherr CJ, Roberts JM. Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 2004;18:2699-711.
    • (2004) Genes Dev , vol.18 , pp. 2699-2711
    • Sherr, C.J.1    Roberts, J.M.2
  • 8
    • 0029033861 scopus 로고
    • The retinoblastoma protein and cell cycle control
    • Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81:323-30.
    • (1995) Cell , vol.81 , pp. 323-330
    • Weinberg, R.A.1
  • 9
    • 0032146274 scopus 로고    scopus 로고
    • The regulation of E2F by pRB-family proteins
    • Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 1998;12:2245-62.
    • (1998) Genes Dev , vol.12 , pp. 2245-2262
    • Dyson, N.1
  • 10
    • 33748047128 scopus 로고    scopus 로고
    • RB and cell cycle progression
    • Giacinti C, Giordano A. RB and cell cycle progression. Oncogene. 2006;25:5220-7.
    • (2006) Oncogene , vol.25 , pp. 5220-5227
    • Giacinti, C.1    Giordano, A.2
  • 11
    • 1942421702 scopus 로고    scopus 로고
    • Cyclin C/cdk3 promotes Rbdependent G0 exit
    • Ren S, Rollins BJ. Cyclin C/cdk3 promotes Rbdependent G0 exit. Cell. 2004;117:239-51.
    • (2004) Cell , vol.117 , pp. 239-251
    • Ren, S.1    Rollins, B.J.2
  • 14
    • 0032919173 scopus 로고    scopus 로고
    • Gene amplification and over expression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation
    • An HX, Beckmann MW, Reifenberger G, Bender HG, Niederacher D. Gene amplification and over expression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation. Am J Pathol. 1999;154:113-8.
    • (1999) Am J Pathol , vol.154 , pp. 113-118
    • An, H.X.1    Beckmann, M.W.2    Reifenberger, G.3    Bender, H.G.4    Niederacher, D.5
  • 16
    • 0030982897 scopus 로고    scopus 로고
    • Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA
    • Costello JF, Plass C, Arap W, Chapman VM, Held WA, Berger MS, Su Huang HJ, Cavenee WK. Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Res. 1997;57:1250-4.
    • (1997) Cancer Res , vol.57 , pp. 1250-1254
    • Costello, J.F.1    Plass, C.2    Arap, W.3    Chapman, V.M.4    Held, W.A.5    Berger, M.S.6    Su, H.H.J.7    Cavenee, W.K.8
  • 20
    • 0029011539 scopus 로고
    • 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/ MTS1 in human cancers
    • Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/ MTS1 in human cancers. Nat Med. 1995;1:686-92.
    • (1995) Nat Med , vol.1 , pp. 686-692
    • Merlo, A.1    Herman, J.G.2    Mao, L.3    Lee, D.J.4    Gabrielson, E.5    Burger, P.C.6    Baylin, S.B.7    Sidransky, D.8
  • 23
    • 62849123093 scopus 로고    scopus 로고
    • Polo-like kinases: Conservation and divergence in their functions and regulation
    • Archambault V, Glover DM. Polo-like kinases: conservation and divergence in their functions and regulation. Nat Rev Mol Cell Biol. 2009;10: 265-75.
    • (2009) Nat Rev Mol Cell Biol , vol.10 , pp. 265-275
    • Archambault, V.1    Glover, D.M.2
  • 24
    • 34948901399 scopus 로고    scopus 로고
    • Aurora-A: The maker and breaker of spindle poles
    • Barr AR, Gergely F. Aurora-A: the maker and breaker of spindle poles. J Cell Sci. 2007;120:2987-96.
    • (2007) J Cell Sci , vol.120 , pp. 2987-2996
    • Barr, A.R.1    Gergely, F.2
  • 25
    • 33645316142 scopus 로고    scopus 로고
    • Targeting Polo-like kinase 1 for cancer therapy
    • Strebhardt K, Ullrich A. Targeting Polo-like kinase 1 for cancer therapy. Nat Rev Cancer. 2006;6:321-30.
    • (2006) Nat Rev Cancer , vol.6 , pp. 321-330
    • Strebhardt, K.1    Ullrich, A.2
  • 27
    • 34447094967 scopus 로고    scopus 로고
    • A census of mitotic cancer genes: New insights into tumor cell biology and cancer therapy
    • Pérez de Castro I, de Cárcer G, Malumbres M. A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy. Carcinogenesis. 2007;28:899-912.
    • (2007) Carcinogenesis , vol.28 , pp. 899-912
    • de Castro, I.P.1    de Cárcer, G.2    Malumbres, M.3
  • 28
    • 0031021648 scopus 로고    scopus 로고
    • Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: Immunocytochemical and quantitative image analyses
    • Kawamoto H, Koizumi H, Uchikoshi T. Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses. Am J Pathol. 1997;150:15-23.
    • (1997) Am J Pathol , vol.150 , pp. 15-23
    • Kawamoto, H.1    Koizumi, H.2    Uchikoshi, T.3
  • 31
    • 0033870724 scopus 로고    scopus 로고
    • Overexpression of Cyclin B1 in Early-Stage Non-Small Cell Lung Cancer and Its Clinical Implication
    • Soria J-C, Jang SJ, Khuri FR, Hassan K, Liu D, Hong WK, Mao L. Overexpression of Cyclin B1 in Early-Stage Non-Small Cell Lung Cancer and Its Clinical Implication. Cancer Res. 2000;60:4000-4.
    • (2000) Cancer Res , vol.60 , pp. 4000-4004
    • Soria, J.-C.1    Jang, S.J.2    Khuri, F.R.3    Hassan, K.4    Liu, D.5    Hong, W.K.6    Mao, L.7
  • 33
    • 0033135640 scopus 로고    scopus 로고
    • Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast
    • Tanaka T, Kimura M, Matsunaga K, Fukada D, Mori H, Okano Y. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res. 1999;59:2041-4.
    • (1999) Cancer Res , vol.59 , pp. 2041-2044
    • Tanaka, T.1    Kimura, M.2    Matsunaga, K.3    Fukada, D.4    Mori, H.5    Okano, Y.6
  • 34
    • 16344376622 scopus 로고    scopus 로고
    • Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer
    • Hu W, Kavanagh JJ, Deaver M, Johnston DA, Freedman RS, Verschraegen CF, Sen S. Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer. Oncol Res. 2005;15:49-57.
    • (2005) Oncol Res , vol.15 , pp. 49-57
    • Hu, W.1    Kavanagh, J.J.2    Deaver, M.3    Johnston, D.A.4    Freedman, R.S.5    Verschraegen, C.F.6    Sen, S.7
  • 39
    • 0033210869 scopus 로고    scopus 로고
    • Prognostic significance of Pololike kinase expression in esophageal carcinoma
    • Tokumitsu Y, Mori M, Tanaka S, Akazawa K, Nakano S, Niho Y. Prognostic significance of Pololike kinase expression in esophageal carcinoma. Int J Oncol. 1999;15:687-692.
    • (1999) Int J Oncol , vol.15 , pp. 687-692
    • Tokumitsu, Y.1    Mori, M.2    Tanaka, S.3    Akazawa, K.4    Nakano, S.5    Niho, Y.6
  • 41
    • 0033564832 scopus 로고    scopus 로고
    • Prognostic Significance of Pololike Kinase (PLK) Expression in Squamous Cell Carcinomas of the Head and Neck
    • Knecht R, Elez R, Oechler M, Solbach C, Ilberg Cv, Strebhardt K. Prognostic Significance of Pololike Kinase (PLK) Expression in Squamous Cell Carcinomas of the Head and Neck. Cancer Res. 1999;59:2794-2797.
    • (1999) Cancer Res , vol.59 , pp. 2794-2797
    • Knecht, R.1    Elez, R.2    Oechler, M.3    Solbach, C.4    Ilberg, C.5    Strebhardt, K.6
  • 43
    • 0035836079 scopus 로고    scopus 로고
    • Expression of Polo-like kinase in ovarian cancer is associated with histological grade and clinical stage
    • Takai N, Miyazaki T, Fujisawa K, Nasu K, Hamanaka R, Miyakawa I. Expression of Polo-like kinase in ovarian cancer is associated with histological grade and clinical stage. Cancer Lett. 2001;164:41-9.
    • (2001) Cancer Lett , vol.164 , pp. 41-49
    • Takai, N.1    Miyazaki, T.2    Fujisawa, K.3    Nasu, K.4    Hamanaka, R.5    Miyakawa, I.6
  • 44
  • 45
    • 0035990398 scopus 로고    scopus 로고
    • Expression of Polo-like kinase (PLK1) in thin melanomas: A novel marker of metastatic disease
    • Kneisel L, Strebhardt K, Bernd A, Wolter M, Binder A, Kaufmann R. Expression of Polo-like kinase (PLK1) in thin melanomas: a novel marker of metastatic disease. J Cutan Pathol. 2002;29:354-8.
    • (2002) J Cutan Pathol , vol.29 , pp. 354-358
    • Kneisel, L.1    Strebhardt, K.2    Bernd, A.3    Wolter, M.4    Binder, A.5    Kaufmann, R.6
  • 46
    • 1942438028 scopus 로고    scopus 로고
    • Microtubules as a target for anticancer drugs
    • Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer. 2004;4:253-65.
    • (2004) Nat Rev Cancer , vol.4 , pp. 253-265
    • Jordan, M.A.1    Wilson, L.2
  • 47
    • 0033375469 scopus 로고    scopus 로고
    • Flavopiridol: The first cyclindependent kinase inhibitor in human clinical trials
    • Senderowicz AM. Flavopiridol: the first cyclindependent kinase inhibitor in human clinical trials. Invest New Drugs. 1999;17:313-20.
    • (1999) Invest New Drugs , vol.17 , pp. 313-320
    • Senderowicz, A.M.1
  • 56
    • 77951082119 scopus 로고    scopus 로고
    • Pharmacologic Inhibition of Cyclin- Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts
    • Michaud K, Solomon DA, Oermann E, Kim J-S, Zhong W-Z, Prados MD, Ozawa T, James CD, Waldman T. Pharmacologic Inhibition of Cyclin- Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts. Cancer Res. 2010;70:3228-38.
    • (2010) Cancer Res , vol.70 , pp. 3228-3238
    • Michaud, K.1    Solomon, D.A.2    Oermann, E.3    Kim, J.-S.4    Zhong, W.-Z.5    Prados, M.D.6    Ozawa, T.7    James, C.D.8    Waldman, T.9
  • 59
    • 0020562188 scopus 로고
    • Effects of Tamoxifen on Cell Cycle Progression of Synchronous MCF-7 Human Mammary Carcinoma Cells
    • Taylor IW, Hodson PJ, Green MD, Sutherland RL. Effects of Tamoxifen on Cell Cycle Progression of Synchronous MCF-7 Human Mammary Carcinoma Cells. Cancer Res. 1983;43:4007-10.
    • (1983) Cancer Res , vol.43 , pp. 4007-4710
    • Taylor, I.W.1    Hodson, P.J.2    Green, M.D.3    Sutherland, R.L.4
  • 63
    • 34548838818 scopus 로고    scopus 로고
    • Pharmacologic inhibition of CDK4/6: Mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia
    • Wang L, Wang J, Blaser BW, Duchemin A-M, Kusewitt DF, Liu T, Caligiuri MA, Briesewitz R. Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia. Blood. 2007;110:2075-83.
    • (2007) Blood , vol.110 , pp. 2075-2083
    • Wang, L.1    Wang, J.2    Blaser, B.W.3    Duchemin, A.-M.4    Kusewitt, D.F.5    Liu, T.6    Caligiuri, M.A.7    Briesewitz, R.8
  • 64
    • 77954757207 scopus 로고    scopus 로고
    • Therapeutic CDK4/6 inhibition in breast cancer: Key mechanisms of response and failure
    • Dean JL, Thangavel C, McClendon AK, Reed CA, Knudsen ES. Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure. Oncogene. 2010;29:4018-32.
    • (2010) Oncogene , vol.29 , pp. 4018-4032
    • Dean, J.L.1    Thangavel, C.2    McClendon, A.K.3    Reed, C.A.4    Knudsen, E.S.5
  • 65
    • 0028172926 scopus 로고
    • Absence of p16(ink4) protein is restricted to the subset of lung-cancer lines that retains wildtype RB
    • Otterson GA, Kratzke RA, Coxon A, Kim YW, Kaye FJ. Absence of p16(ink4) protein is restricted to the subset of lung-cancer lines that retains wildtype RB. Oncogene. 1994;9:3375-8.
    • (1994) Oncogene , vol.9 , pp. 3375-3378
    • Otterson, G.A.1    Kratzke, R.A.2    Coxon, A.3    Kim, Y.W.4    Kaye, F.J.5
  • 68
    • 27144458683 scopus 로고    scopus 로고
    • Cyclins and CDKS in development and cancer: Lessons from genetically modified mice
    • Santamaria D, Ortega S. Cyclins and CDKS in development and cancer: lessons from genetically modified mice. Front Biosci. 2006;11:1164-88.
    • (2006) Front Biosci , vol.11 , pp. 1164-1188
    • Santamaria, D.1    Ortega, S.2
  • 75
    • 79952443627 scopus 로고    scopus 로고
    • The cyclin-dependent kinase inhibitor SNS-032 has single agent activity in AML cells and is highly synergistic with cytarabine
    • Walsby E, Lazenby M, Pepper C, Burnett AK. The cyclin-dependent kinase inhibitor SNS-032 has single agent activity in AML cells and is highly synergistic with cytarabine. Leukemia. 2011;25:411-9.
    • (2011) Leukemia , vol.25 , pp. 411-419
    • Walsby, E.1    Lazenby, M.2    Pepper, C.3    Burnett, A.K.4
  • 76
    • 67650038523 scopus 로고    scopus 로고
    • The small-molecule CDK inhibitor, SNS-032, enhances cellular radiosensitivity in quiescent and hypoxic non-small cell lung cancer cells
    • Kodym E, Kodym R, Reis AE, Habib AA, Story MD, Saha D. The small-molecule CDK inhibitor, SNS-032, enhances cellular radiosensitivity in quiescent and hypoxic non-small cell lung cancer cells. Lung Cancer. 2009;66:37-47.
    • (2009) Lung Cancer , vol.66 , pp. 37-47
    • Kodym, E.1    Kodym, R.2    Reis, A.E.3    Habib, A.A.4    Story, M.D.5    Saha, D.6
  • 78
    • 33747872306 scopus 로고    scopus 로고
    • A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6
    • Baughn LB, Di Liberto M, Wu K, Toogood PL, Louie T, Gottschalk R, Niesvizky R, Cho H, Ely S, Moore MA, Chen-Kiang S. A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6. Cancer Res. 2006;66:7661-7.
    • (2006) Cancer Res , vol.66 , pp. 7661-7667
    • Baughn, L.B.1    di Liberto, M.2    Wu, K.3    Toogood, P.L.4    Louie, T.5    Gottschalk, R.6    Niesvizky, R.7    Cho, H.8    Ely, S.9    Moore, M.A.10    Chen-Kiang, S.11
  • 79
    • 79959466807 scopus 로고    scopus 로고
    • Forced Expression of Cyclin-Dependent Kinase 6 Confers Resistance of Pro-B Acute Lymphocytic Leukemia to Gleevec Treatment
    • Kuo TC, Chavarria-Smith JE, Huang D, Schlissel MS. Forced Expression of Cyclin-Dependent Kinase 6 Confers Resistance of Pro-B Acute Lymphocytic Leukemia to Gleevec Treatment. Mol Cell Biol. 2011;31:2566-76.
    • (2011) Mol Cell Biol , vol.31 , pp. 2566-2576
    • Kuo, T.C.1    Chavarria-Smith, J.E.2    Huang, D.3    Schlissel, M.S.4
  • 81
    • 33747128468 scopus 로고    scopus 로고
    • Molecular and pharmacodynamic characteristics of the novel multi-target tumor growth inhibitor ZK 304709
    • Siemeister G, Luecking U, Wagner C, Detjen K, Mc Coy C, Bosslet K. Molecular and pharmacodynamic characteristics of the novel multi-target tumor growth inhibitor ZK 304709. Biomed Pharmacother. 2006;60:269-72.
    • (2006) Biomed Pharmacother , vol.60 , pp. 269-272
    • Siemeister, G.1    Luecking, U.2    Wagner, C.3    Detjen, K.4    McCoy, C.5    Bosslet, K.6
  • 83
    • 70349180350 scopus 로고    scopus 로고
    • Validated bioanalytical method for the quantification of RGB-286638, a novel multitargeted protein kinase inhibitor, in human plasma and urine by liquid chromatography/tandem triplequadrupole mass spectrometry
    • de Bruijn P, Moghaddam-Helmantel IMG, de Jonge MJA, Meyer T, Lam M-H, Verweij J, Wiemer EAC, Loos WJ. Validated bioanalytical method for the quantification of RGB-286638, a novel multitargeted protein kinase inhibitor, in human plasma and urine by liquid chromatography/tandem triplequadrupole mass spectrometry. J Pharm Biomed Anal. 2009;50:977-82.
    • (2009) J Pharm Biomed Anal , vol.50 , pp. 977-982
    • de Bruijn, P.1    Moghaddam-Helmantel, I.M.G.2    de Jonge, M.J.A.3    Meyer, T.4    Lam, M.-H.5    Verweij, J.6    Wiemer, E.A.C.7    Loos, W.J.8
  • 87
    • 0037374549 scopus 로고    scopus 로고
    • Selective Cyclin-dependent Kinase 2/Cyclin A Antagonists that Differ from ATP Site Inhibitors Block Tumor Growth
    • Mendoza N, Fong S, Marsters J, Koeppen H, Schwall R, Wickramasinghe D. Selective Cyclin-dependent Kinase 2/Cyclin A Antagonists that Differ from ATP Site Inhibitors Block Tumor Growth. Cancer Res. 2003;63:1020-4.
    • (2003) Cancer Res , vol.63 , pp. 1020-1024
    • Mendoza, N.1    Fong, S.2    Marsters, J.3    Koeppen, H.4    Schwall, R.5    Wickramasinghe, D.6
  • 88
    • 33845980608 scopus 로고    scopus 로고
    • Identification of an Hexapeptide That Binds to a Surface Pocket in Cyclin A and Inhibits the Catalytic Activity of the Complex Cyclin-dependent Kinase 2-Cyclin A
    • Canela N, Orzáez M, Fucho R, Mateo F, Gutierrez R, Pineda-Lucena A, Bachs O, Pérez-Payá E. Identification of an Hexapeptide That Binds to a Surface Pocket in Cyclin A and Inhibits the Catalytic Activity of the Complex Cyclin-dependent Kinase 2-Cyclin A. J Biol Chem. 2006;281:35942-53.
    • (2006) J Biol Chem , vol.281 , pp. 35942-35953
    • Canela, N.1    Orzáez, M.2    Fucho, R.3    Mateo, F.4    Gutierrez, R.5    Pineda-Lucena, A.6    Bachs, O.7    Pérez-Payá, E.8
  • 90
    • 33947498211 scopus 로고    scopus 로고
    • A small molecule based on the pRb2/p130 spacer domain leads to inhibition of cdk2 activity, cell cycle arrest and tumor growth reduction in vivo
    • Bagella L, Sun A, Tonini T, Abbadessa G, Cottone G, Paggi MG, De Luca A, Claudio PP, Giordano A. A small molecule based on the pRb2/p130 spacer domain leads to inhibition of cdk2 activity, cell cycle arrest and tumor growth reduction in vivo. Oncogene. 2007;26:1829-39.
    • (2007) Oncogene , vol.26 , pp. 1829-1839
    • Bagella, L.1    Sun, A.2    Tonini, T.3    Abbadessa, G.4    Cottone, G.5    Paggi, M.G.6    de Luca, A.7    Claudio, P.P.8    Giordano, A.9
  • 91
    • 28044454553 scopus 로고    scopus 로고
    • Current strategies for the development of peptide-based anti-cancer therapeutics
    • Borghouts C, Kunz C, Groner B. Current strategies for the development of peptide-based anti-cancer therapeutics. J Pept Sci. 2005;11:713-26.
    • (2005) J Pept Sci , vol.11 , pp. 713-726
    • Borghouts, C.1    Kunz, C.2    Groner, B.3
  • 92
    • 70349383205 scopus 로고    scopus 로고
    • 3rd. Therapeutic peptides for cancer therapy. Part II - cell cycle inhibitory peptides and apoptosis-inducing peptides
    • Raucher D, Moktan S, Massodi I, Bidwell GL, 3rd. Therapeutic peptides for cancer therapy. Part II - cell cycle inhibitory peptides and apoptosis-inducing peptides. Expert Opin Drug Deliv. 2009;6:1049-64.
    • (2009) Expert Opin Drug Deliv , vol.6 , pp. 1049-1064
    • Raucher, D.1    Moktan, S.2    Massodi, I.3    Bidwell, G.L.4
  • 93
    • 79959952060 scopus 로고    scopus 로고
    • Somatic variation and cancer: Therapies lost in the mix
    • Biankin AV, Hudson TJ. Somatic variation and cancer: therapies lost in the mix. Hum Genet. 2011;130:79-91.
    • (2011) Hum Genet , vol.130 , pp. 79-91
    • Biankin, A.V.1    Hudson, T.J.2
  • 95
    • 10344236486 scopus 로고    scopus 로고
    • Aurora-kinase inhibitors as anticancer agents
    • Keen N, Taylor S. Aurora-kinase inhibitors as anticancer agents. Nat Rev Cancer. 2004;4:927-36.
    • (2004) Nat Rev Cancer , vol.4 , pp. 927-936
    • Keen, N.1    Taylor, S.2
  • 96
  • 97
    • 39149089275 scopus 로고    scopus 로고
    • Polo and Aurora kinases: Lessons derived from chemical biology
    • Taylor S, Peters JM. Polo and Aurora kinases: lessons derived from chemical biology. Curr Opin Cell Biol. 2008;20:77-84.
    • (2008) Curr Opin Cell Biol , vol.20 , pp. 77-84
    • Taylor, S.1    Peters, J.M.2
  • 98
    • 0032213515 scopus 로고    scopus 로고
    • Multinuclearity and Increased Ploidy Caused by Overexpression of the Auroraand Ipl1-like Midbody-associated Protein Mitotic Kinase in Human Cancer Cells
    • Tatsuka M, Katayama H, Ota T, Tanaka T, Odashima S, Suzuki F, Terada Y. Multinuclearity and Increased Ploidy Caused by Overexpression of the Auroraand Ipl1-like Midbody-associated Protein Mitotic Kinase in Human Cancer Cells. Cancer Res. 1998;58:4811-6.
    • (1998) Cancer Res , vol.58 , pp. 4811-4816
    • Tatsuka, M.1    Katayama, H.2    Ota, T.3    Tanaka, T.4    Odashima, S.5    Suzuki, F.6    Terada, Y.7
  • 99
    • 27744511262 scopus 로고    scopus 로고
    • Aurora-B//AIM-1 kinase activity is involved in Ras-mediated cell transformation
    • Kanda A, Kawai H, Suto S, Kitajima S, Sato S, Takata T, Tatsuka M. Aurora-B//AIM-1 kinase activity is involved in Ras-mediated cell transformation. Oncogene. 2005;24:7266-72.
    • (2005) Oncogene , vol.24 , pp. 7266-7272
    • Kanda, A.1    Kawai, H.2    Suto, S.3    Kitajima, S.4    Sato, S.5    Takata, T.6    Tatsuka, M.7
  • 100
    • 0037105758 scopus 로고    scopus 로고
    • Increased Mitotic Phosphorylation of Histone H3 Attributable to AIM-1/Aurora-B Overexpression Contributes to Chromosome Number Instability
    • Ota T, Suto S, Katayama H, Han Z-B, Suzuki F, Maeda M, Tanino M, Terada Y, Tatsuka M. Increased Mitotic Phosphorylation of Histone H3 Attributable to AIM-1/Aurora-B Overexpression Contributes to Chromosome Number Instability. Cancer Res. 2002;62:5168-77.
    • (2002) Cancer Res , vol.62 , pp. 5168-5177
    • Ota, T.1    Suto, S.2    Katayama, H.3    Han, Z.-B.4    Suzuki, F.5    Maeda, M.6    Tanino, M.7    Terada, Y.8    Tatsuka, M.9
  • 101
    • 79956223049 scopus 로고    scopus 로고
    • Aurora kinase inhibitor patents and agents in clinical testing: An update (2009-10)
    • Cheung CH, Coumar MS, Chang JY, Hsieh HP. Aurora kinase inhibitor patents and agents in clinical testing: an update (2009-10). Expert Opin Ther Pat. 2011;21:857-84.
    • (2011) Expert Opin Ther Pat , vol.21 , pp. 857-884
    • Cheung, C.H.1    Coumar, M.S.2    Chang, J.Y.3    Hsieh, H.P.4
  • 103
    • 2942615282 scopus 로고    scopus 로고
    • Polo-like kinases and the orchestration of cell division
    • Barr FA, Sillje HHW, Nigg EA. Polo-like kinases and the orchestration of cell division. Nat Rev Mol Cell Biol. 2004;5:429-41.
    • (2004) Nat Rev Mol Cell Biol , vol.5 , pp. 429-441
    • Barr, F.A.1    Sillje, H.H.W.2    Nigg, E.A.3
  • 104
    • 33745234790 scopus 로고    scopus 로고
    • Down-regulation of Polo-like kinase 1 elevates drug sensitivity of breast cancer cells in vitro and in vivo
    • Spankuch B, Heim S, Kurunci-Csacsko E, Lindenau C, Yuan J, Kaufmann M, Strebhardt K. Down-regulation of Polo-like kinase 1 elevates drug sensitivity of breast cancer cells in vitro and in vivo. Cancer Res. 2006;66:5836-46.
    • (2006) Cancer Res , vol.66 , pp. 5836-5846
    • Spankuch, B.1    Heim, S.2    Kurunci-Csacsko, E.3    Lindenau, C.4    Yuan, J.5    Kaufmann, M.6    Strebhardt, K.7
  • 105
    • 33644767315 scopus 로고    scopus 로고
    • Normal Cells, but Not Cancer Cells, Survive Severe Plk1 Depletion
    • Liu X, Lei M, Erikson RL. Normal Cells, but Not Cancer Cells, Survive Severe Plk1 Depletion. Mol Cell Biol. 2006;26:2093-108.
    • (2006) Mol Cell Biol , vol.26 , pp. 2093-2108
    • Liu, X.1    Lei, M.2    Erikson, R.L.3
  • 106
    • 79959696118 scopus 로고    scopus 로고
    • PLK1 as an oncology target: Current status and future potential
    • McInnes C, Wyatt MD. PLK1 as an oncology target: current status and future potential. Drug Discov Today. 2011;16:619-25.
    • (2011) Drug Discov Today , vol.16 , pp. 619-625
    • McInnes, C.1    Wyatt, M.D.2
  • 107
    • 17144385867 scopus 로고    scopus 로고
    • Structure and inhibition of the human cell cycle checkpoint kinase, Wee1A kinase: An atypical tyrosine kinase with a key role in CDK1 regulation
    • Squire CJ, Dickson JM, Ivanovic I, Baker EN. Structure and inhibition of the human cell cycle checkpoint kinase, Wee1A kinase: an atypical tyrosine kinase with a key role in CDK1 regulation. Structure. 2005;13:541-50.
    • (2005) Structure , vol.13 , pp. 541-550
    • Squire, C.J.1    Dickson, J.M.2    Ivanovic, I.3    Baker, E.N.4
  • 110
    • 13844252061 scopus 로고    scopus 로고
    • The kinase haspin is required for mitotic histone H3 Thr 3 phosphorylation and normal metaphase chromosome alignment
    • Dai J, Sultan S, Taylor SS, Higgins JM. The kinase haspin is required for mitotic histone H3 Thr 3 phosphorylation and normal metaphase chromosome alignment. Genes Dev. 2005;19:472-88.
    • (2005) Genes Dev , vol.19 , pp. 472-488
    • Dai, J.1    Sultan, S.2    Taylor, S.S.3    Higgins, J.M.4
  • 112
    • 0015223149 scopus 로고
    • Genetic control of the cell division cycle in yeast. II. Genes controlling DNA replication and its initiation
    • Hartwell LH. Genetic control of the cell division cycle in yeast. II. Genes controlling DNA replication and its initiation. J Mol Biol. 1971;59:183-94.
    • (1971) J Mol Biol , vol.59 , pp. 183-194
    • Hartwell, L.H.1
  • 113
    • 50949102890 scopus 로고    scopus 로고
    • Cdc7-Dbf4 kinase overexpression in multiple cancers and tumor cell lines is correlated with p53 inactivation
    • Bonte D, Lindvall C, Liu H, Dykema K, Furge K, Weinreich M. Cdc7-Dbf4 kinase overexpression in multiple cancers and tumor cell lines is correlated with p53 inactivation. Neoplasia. 2008; 10:920-31.
    • (2008) Neoplasia , vol.10 , pp. 920-931
    • Bonte, D.1    Lindvall, C.2    Liu, H.3    Dykema, K.4    Furge, K.5    Weinreich, M.6
  • 114
    • 77956713455 scopus 로고    scopus 로고
    • Targeting cell division cycle 7 kinase: A new approach for cancer therapy
    • Montagnoli A, Moll J, Colotta F. Targeting cell division cycle 7 kinase: a new approach for cancer therapy. Clin Cancer Res. 2010;16:4503-8.
    • (2010) Clin Cancer Res , vol.16 , pp. 4503-4508
    • Montagnoli, A.1    Moll, J.2    Colotta, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.